Tag newsletter

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—September 2024 Newsletter

Speaking of Mol Bio Podcast In the latest episode (Season 2, Episode 8) of the Speaking of Mol Bio Podcast, hosts Steve Lewis and Dr. Christian Cobaugh, CEO of Vernal Biosciences, delve into the fascinating world of mRNA technology. The…

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—August 2024 Newsletter

Rapid Single Epitope mRNA Production This article presents a synthetic DNA template (SDT) process for manufacturing single epitope mRNA, offering a flexible, cost-efficient, and rapid alternative to traditional plasmid DNA templates (PDT). Read the article to explore what can be…

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—July 2024 Newsletter

Phase 2b Autoimmune CAR-T Win Congratulations to Cartesian Therapeutics on their Phase 2b autoimmune CAR-T trial success—shifting the intensity of the cell therapy paradigm! This milestone is a testament to their innovation. It’s exciting to see mRNA as part of…

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—June 2024 Newsletter

mRNA Capping TechnologiesExplore this study, which compares two important mRNA capping technologies by evaluating the mRNA integrity, percent Cap1 content, dsRNA content, in vivo expression and innate immune activation in mice. Download the Poster 7 Key Benefits of a US-Based…

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—May 2024 Newsletter

From the FounderWelcome to the NEW monthly mRNA newsletter! In this monthly update, we will share the latest breakthroughs, insights, and innovations in mRNA and mRNA-LNP technology. By reading these updates, you will gain a competitive edge, stay ahead of…